Tests a behavior program for young people who use stimulants and have sex
Tests a behavior program in young people aged 16 to 24 who use stimulants.
Plain-language title generated from the registry record
Registry title: Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
Key facts
- Where
- Los Angeles and Providence, United StatesSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 16 and 24 years old?
Source: NCT06444360, who can take part
Where in United States
- University of California, Los AngelesLos Angeles, United StatesTaking people
- Brown UniversityProvidence, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Westat
- Trial code
- NCT06444360
- Record updated
- 2 November 2026
- Original description
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.Read full original descriptionShow less
Hybrid Type 2 Effectiveness-Implementation Trial of Status Neutral, Integrated Behavioral Activation and Risk Reduction Intervention for Stimulant Use Among Sexually Active Adolescents and Young Adults (Project IMPACT)
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
Inclusion: Age 16-24 years, inclusive, at enrollment; Self-reports condomless sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined as crystal methamphetamine, cocaine, and MDMA (e.g., ecstasy, molly); Willing and able to provide written informed consent for study participation; Access to a computer/smartphone/tablet that can use video chat (e.g., Zoom or Google Meet); Provide a mailing address where they can receive a package; Access to stable internet that they can use for more than 2 hours at a time; Have a private place (where no one else can see or hear) where they can complete visits online; Reside within the continental U.S.
Exclusion: Concurrent enrollment in another HIV prevention or treatment study (enrollment in a substance treatment program is acceptable); Randomized to IMPACT arm of study prior to March 2025 study pause; Unable to provide informed consent due to severe mental or physical illness; Any other medical condition, medical/behavioral intervention, or other condition that, in the opinion of the Project Lead or designee, could interfere with the safety of participants or staff, adherence to study procedures, or compromise interpretation of study results; Non-English-speaking; Is currently incarcerated or pending incarceration; Is currently pregnant or planning to become pregnant.